Novel Start Trial



Can’t sign in or forgot your password?

Enter your email address and we will send you password reset instructions.

Enter your email address


      Nevermind, send me back to the log in screen
   

Site User?

You don’t have an email address so you need to contact your local coordinator or principle investigator to have your password reset.

 

About the Novel START Study

The Novel START (Novel Symbicort Turbuhaler Asthma Reliever Therapy) study is a 52- week, open label, parallel group, multicentre, phase III, randomised controlled trial to compare the efficacy and safety of three asthma treatment regimens.

Participants will be recruited from sites in 9 regions in 4 countries (New Zealand, Australia, Italy and the United Kingdom).

About the software

Spinnaker is a tailored, web based, software and database solution for managing your multi-centre clinical study including the recording of patient data, recording and alerting of events, inventory management and reporting on data collected during the course of your study. Spinnaker is user friendly, adaptable and can be delivered quickly. You can read more on the Spinnaker website or contact Audrey on spinnaker@spiral.co.nz.

 

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.